Cargando…
Nine per cent of biopsy‐proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery
Autores principales: | Zoutendijk, J., Tio, D., Koljenovic, S., van den Bos, R.R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850063/ https://www.ncbi.nlm.nih.gov/pubmed/30716164 http://dx.doi.org/10.1111/bjd.17714 |
Ejemplares similares
-
Clinical findings are not helpful in detecting lentigo maligna melanoma in patients with biopsy‐proven lentigo maligna
por: Zoutendijk, J., et al.
Publicado: (2022) -
Reviewing Challenges in the Diagnosis and Treatment of Lentigo Maligna and Lentigo-Maligna Melanoma
por: Juhász, Margit L. W., et al.
Publicado: (2015) -
Radiotherapy for lentigo maligna and lentigo maligna melanoma – a systematic review
por: Hendrickx, Alexandra, et al.
Publicado: (2020) -
Is dermoscopy a good tool for the diagnosis of lentigo maligna and lentigo maligna melanoma? A meta-analysis
por: Carapeba, Murilo de Oliveira Lima, et al.
Publicado: (2019) -
Ten-year Follow-up Study of Grenz Ray Treatment for Lentigo Maligna and Early Lentigo Maligna Melanoma
por: DRAKENSJÖ, Iara R. T., et al.
Publicado: (2020)